The prediction of short-term and long-term treatment response to sertraline in panic disorder.
Completed
- Conditions
- Outpatient study at the University Outpatient Clinic, Department of Psychiatry Groningen.
- Registration Number
- NL-OMON21722
- Lead Sponsor
- Pfizer
- Brief Summary
In preparation.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 57
Inclusion Criteria
1. Panic Disorder According to DSM-IV.
2. 2 panic attacks in medication-free run-in period.
Exclusion Criteria
1. Comorbid psychotic disorder, alcolhol abuse, major affective disorder or personality disorder in the last year.
2. Participation in other drug trial 30 days prior to selection.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To identify variables mentioned above (at baseline) that can predict short-term and long-term response to treatment with sertraline in Panic Disorder.
- Secondary Outcome Measures
Name Time Method To establish whether autonomous nervous system (ANS) functioning is a state marker of illness severity, and:<br /><br>to establish whether treatment with sertraline has an affect on the functioning of the ANS.